VSee Health, Inc. (NASDAQ:VSEE – Get Free Report) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totaling 1,048,440 shares, a decline of 45.9% from the May 31st total of 1,936,650 shares. Based on an average trading volume of 1,741,369 shares, the days-to-cover ratio is currently 0.6 days.
Institutional Investors Weigh In On VSee Health
A hedge fund recently raised its stake in VSee Health stock. Osaic Holdings Inc. increased its stake in shares of VSee Health, Inc. (NASDAQ:VSEE – Free Report) by 197.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 45,170 shares of the company’s stock after acquiring an additional 29,985 shares during the quarter. Osaic Holdings Inc. owned about 1.25% of VSee Health worth $52,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 1.01% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of VSee Health in a research note on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.
VSee Health Price Performance
VSEE stock traded up $0.00 during trading on Wednesday, reaching $0.12. The company’s stock had a trading volume of 337,770 shares, compared to its average volume of 1,349,162. The company has a current ratio of 0.41, a quick ratio of 0.41 and a debt-to-equity ratio of 0.12. The company’s fifty day moving average is $0.16 and its 200-day moving average is $0.28. VSee Health has a 1 year low of $0.10 and a 1 year high of $2.52.
VSee Health (NASDAQ:VSEE – Get Free Report) last announced its quarterly earnings data on Friday, May 15th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.06. VSee Health had a negative return on equity of 11,636.34% and a negative net margin of 92.36%.The business had revenue of $3.16 million for the quarter, compared to the consensus estimate of $4.80 million.
VSee Health Company Profile
VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.
In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.
Featured Articles
- Five stocks we like better than VSee Health
- Ouster Is Breaking Out as a Physical AI Leader: Here’s What’s Driving the Move
- Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push
- 3 Big Banks Plan Double Digit Dividend Increases After Passing Fed Stress Test
- 3 ETFs Offering Exposure to Latin America’s Stock Market Rally
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
